微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -1.62% | -52.83% | 15.18% | 41/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | -1.91% | -81.9% | -185.07% | 40/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | -0.67% | -1016.67% | 88.61% | 37/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | -5.88% | -185.44% | -454.72% | 42/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | -1.06% | -232.5% | -0.95% | 44/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | -1.05% | -400% | -1650% | 44/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | -0.06% | -118.18% | 97.09% | 36/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | -2.06% | -764.52% | -357.5% | 38/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 0.8% | -25.23% | 128.57% | 39/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 0.35% | 84.21% | 6.06% | 38/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 0.33% | 120% | 6.45% | 33/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 0.31% | 112.76% | -71.03% | 39/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 1.07% | 278.33% | 463.16% | 30/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 0.19% | 121.59% | 26.67% | 38/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 0.15% | -37.5% | 106.17% | 26/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | -2.43% | -219.7% | -305% | 42/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | -0.6% | -115.19% | 31.82% | 25/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | -0.88% | -138.6% | -466.67% | 30/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | 0.24% | -86.21% | -88.18% | 17/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 2.03% | -47.55% | -48.61% | 37/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 3.95% | -13.76% | 73.25% | 21/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 2.28% | 41.61% | 31.03% | 20/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 1.74% | 20.83% | -55.04% | 16/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | 3.87% | -67.88% | -15.5% | 31/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 4.58% | -66.81% | 184.47% | 17/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 1.61% | -82.03% | 11.81% | 22/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 1.44% | 2% | -88.05% | 16/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 12.05% | -45.94% | -12.68% | 14/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 13.8% | 2% | 54.02% | 6/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 8.96% | 2% | -59.8% | 7/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2016-12-31 | 22.29% | 80.05% | 80.05% | 7/51 | 23.06% | 南华生物 | 1666.98% | 行业排名> |
| 2015-12-31 | 12.38% | -52.75% | -52.75% | 12/51 | 22.23% | 爱尔眼科 | 5.19% | 行业排名> |